Skip to main content
NIH funding notice PAR-15-040

Investigator Initiated Extended Clinical Trial (R01)

Closed on December 4, 2015.

Posted
November 18, 2014
Close date
December 4, 2015
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,271,682 in first-year total cost, median $2,135,841.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 ALW-I (M2)]1
  2. Special Emphasis Panel[ZAI1 LG-M (S2)]1

Most frequent institutions

  1. BOSTON CHILDREN'S HOSPITAL1
  2. MICHIGAN STATE UNIVERSITY1
Competing awards under PAR-15-040 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Treating Brain Swelling in Pediatric Cerebral Malaria1U01AI126610-01TAYLOR, TERRIE ELLENMICHIGAN STATE UNIVERSITY, MI$1,428,188ZAI1
2016Controlling and preventing Asthma progression and Severity in Kids (CASK)1U01AI126614-01PHIPATANAKUL, WANDABOSTON CHILDREN'S HOSPITAL, MA$2,843,494ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.